期刊
VACCINE
卷 31, 期 52, 页码 6225-6231出版社
ELSEVIER SCI LTD
DOI: 10.1016/j.vaccine.2013.10.034
关键词
Toxoplasma gondii; Toxoplasmosis; Eukaryotic initiation factor-2 alpha (TgIF2 alpha); DNA vaccine; Protective immunity; Mice
资金
- National Natural Science Foundation of China [31230073, 31172316, 31101812]
- International Science and Technology Cooperation Project of Gansu Province [1204WCGA023]
- Science Fund for Creative Research Groups of Gansu Province [1210RJIA006]
Toxoplasma gondii infection is a serious health problem of humans and animals worldwide. T. gondii eukaryotic initiation factor-2 alpha (TgIF2 alpha) plays a crucial role in parasite viability and is an important virulence factor of T. gondii. To evaluate the vaccine potential of TgIF2 alpha, we constructed a novel eukaryotic plasmid pVAX-IF2 alpha expressing TgIF2 alpha from the RH strain and validated expression and immunogenicity in vitro in the Marc145 cell expression system by indirect immunofluorescence (IFA). Administration of pVAX-IF2 alpha intramuscularly induced specific humoral immune responses including high levels of specific TgIF2 alpha IgG antibody and a mixed IgG1/IgG2 alpha response with a predominance of IgG2 alpha production. The cellular immune response was elicited, showing significant production of IFN-gamma and IL-2 associated with Th1 type response, and thus strong cell-mediated cytotoxic activity with increased frequencies of IFN-gamma parameters analyzed in both CD4(+) and CD8(+) T cell compartments (CD4(+) IFN-gamma(+) T cells and CD8(+) IFN-gamma(+) T cells). Immunization resulted in partial protection against acute and chronic toxoplamosis in outbred Kunming mice, demonstrated by a significantly prolonged survival time (15.9 +/- 4.6 days) after challenge with the virulent RH strain and significant reduction in brain cysts (44.1%) against chronic infection with PRU cyst in contrast to control mice. Our data suggested that pVAX-IF2 alpha could be used as a DNA vaccine candidate against both acute and chronic T. gondii infection by the activation of effective humoral and cellular immune responses. (C) 2013 Elsevier Ltd. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据